149 related articles for article (PubMed ID: 14725656)
1. Surgical treatment of nonmelanoma skin cancer in the Medicare population.
Manternach T; Housman TS; Williford PM; Teuschler H; Fleischer AB; Feldman SR; Chen GJ
Dermatol Surg; 2003 Dec; 29(12):1167-9; discussion 1169. PubMed ID: 14725656
[TBL] [Abstract][Full Text] [Related]
2. Nonmelanoma skin cancer treatment training varies across different medical specialists.
Romero PC; Kinney MA; Taylor SL; Levender MM; David LR; Goldman ND; Khanna VC; Williford PM; Feldman SR
J Dermatolog Treat; 2013 Jun; 24(3):215-20. PubMed ID: 22385124
[TBL] [Abstract][Full Text] [Related]
3. Physician specialty cost differences of treating nonmelanoma skin cancer.
Chirikov VV; Stuart B; Zuckerman IH; Christy MR
Ann Plast Surg; 2015 Jan; 74(1):93-9. PubMed ID: 24503881
[TBL] [Abstract][Full Text] [Related]
4. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
[TBL] [Abstract][Full Text] [Related]
5. No end in sight: the skin cancer epidemic continues.
Donaldson MR; Coldiron BM
Semin Cutan Med Surg; 2011 Mar; 30(1):3-5. PubMed ID: 21540015
[TBL] [Abstract][Full Text] [Related]
6. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare.
Joseph AK; Mark TL; Mueller C
Dermatol Surg; 2001 Nov; 27(11):955-9. PubMed ID: 11737130
[TBL] [Abstract][Full Text] [Related]
7. The economic impact of non-melanoma skin cancer: a review.
Mudigonda T; Pearce DJ; Yentzer BA; Williford P; Feldman SR
J Natl Compr Canc Netw; 2010 Aug; 8(8):888-96. PubMed ID: 20870635
[TBL] [Abstract][Full Text] [Related]
8. Nonmelanoma skin cancer: an episode of care management approach.
Housman TS; Williford PM; Feldman SR; Teuschler HV; Fleischer AB; Goldman ND; Balkrishnan R; Chen GJ
Dermatol Surg; 2003 Jul; 29(7):700-11. PubMed ID: 12828693
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of office-based visits for skin cancer. Dermatologists have more experience than other physicians in managing malignant and premalignant skin conditions.
Smith ES; Feldman SR; Fleischer AB; Leshin B; McMichael A
Dermatol Surg; 1998 Sep; 24(9):981-5. PubMed ID: 9754086
[TBL] [Abstract][Full Text] [Related]
10. Cost of nonmelanoma skin cancer treatment in the United States.
Chen JG; Fleischer AB; Smith ED; Kancler C; Goldman ND; Williford PM; Feldman SR
Dermatol Surg; 2001 Dec; 27(12):1035-8. PubMed ID: 11849266
[TBL] [Abstract][Full Text] [Related]
11. The cutaneous surgery experience of multiple specialties in the Medicare population.
Shaffer CL; Feldman SR; Fleischer AB; Huether MJ; Chen GJ
J Am Acad Dermatol; 2005 Jun; 52(6):1045-8. PubMed ID: 15928623
[TBL] [Abstract][Full Text] [Related]
12. Surgical Volume of Dermatologists Who Do Not Perform Mohs Micrographic Dermatologic Surgery: A Cross-Sectional Individual-Level Analysis Using Medicare Data.
Kantor J
Dermatol Surg; 2020 Jan; 46(1):1-6. PubMed ID: 31188146
[TBL] [Abstract][Full Text] [Related]
13. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
14. An ecological study of skin biopsies and skin cancer treatment procedures in the United States Medicare population, 2000 to 2015.
Wang DM; Morgan FC; Besaw RJ; Schmults CD
J Am Acad Dermatol; 2018 Jan; 78(1):47-53. PubMed ID: 28947293
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns and cost of nonmelanoma skin cancer management.
John Chen G; Yelverton CB; Polisetty SS; Housman TS; Williford PM; Teuschler HV; Feldman SR
Dermatol Surg; 2006 Oct; 32(10):1266-71. PubMed ID: 17034377
[TBL] [Abstract][Full Text] [Related]
16. British Association of Dermatologists' national audit on nonmelanoma skin cancer excision, 2014.
Keith DJ; de Berker DA; Bray AP; Cheung ST; Brain A; Mohd Mustapa MF
Clin Exp Dermatol; 2017 Jan; 42(1):46-53. PubMed ID: 28028856
[TBL] [Abstract][Full Text] [Related]
17. Analysis of skin cancer treatment and costs in the United States Medicare population, 1996-2008.
Rogers HW; Coldiron BM
Dermatol Surg; 2013 Jan; 39(1 Pt 1):35-42. PubMed ID: 23199014
[TBL] [Abstract][Full Text] [Related]
18. Incidence estimate of nonmelanoma skin cancer in the United States, 2006.
Rogers HW; Weinstock MA; Harris AR; Hinckley MR; Feldman SR; Fleischer AB; Coldiron BM
Arch Dermatol; 2010 Mar; 146(3):283-7. PubMed ID: 20231499
[TBL] [Abstract][Full Text] [Related]
19. Nonmelanoma Skin Cancer With Aggressive Subclinical Extension in Immunosuppressed Patients.
Song SS; Goldenberg A; Ortiz A; Eimpunth S; Oganesyan G; Jiang SI
JAMA Dermatol; 2016 Jun; 152(6):683-90. PubMed ID: 26981734
[TBL] [Abstract][Full Text] [Related]
20. Years of dermatology experience and geographic region are associated with outlier performance of excision or destruction for nonmelanoma skin cancer.
Woodie BR; Neltner SA; Pauley AG; Fleischer AB
J Dermatolog Treat; 2023 Dec; 34(1):2192839. PubMed ID: 36932466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
